NPAS2 Contributes to Liver Fibrosis by Direct Transcriptional Activation of Hes1 in Hepatic Stellate Cells

Tao Yang,Peng Yuan,Yi Yang,Ning Liang,Qian Wang,Jing Li,Rui Lu,Hongxin Zhang,Jiao Mu,Zhaoyong Yan,Hulin Chang

DOI: https://doi.org/10.1016/j.omtn.2019.10.025

2019-12-01

Abstract:<p>Recently, emerging evidences show that dysregulation of circadian genes is closely associated with liver fibrosis. However, how dysregulation of circadian genes promote liver fibrosis is unknown. Here, we show that NPAS2, one of the core circadian molecules which has been shown to promotes hepatocarcinoma cells proliferation, significantly contributed to the liver fibrogenesis. NPAS2 is upregulated in the HSCs after fibrogenic injury, which subsequently contributes to the activation of HSC. Mechanistically, NPAS2 plays a profibrotic role via directly transcriptional activating Hes1, an ctirical transcriptor of Notch signaling for fibrogenesis process, in hepatic stellate cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Our findings demonstrate that NPAS2 plays a critical role in liver fibrosis through directly transcriptional activation of Hes1, indicating that NPAS2 may serve as an important therapeutic target to reverse the progression of liver fibrosis.</p>